Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Indolent lymphomas; advances from ASH 2012

Dr Mathias Rummel - Universitaetsklinik, Giessen, Germany

Indolent lymphomas; advances from ASH 2012 ( Dr Mathias Rummel - Universitaetsklinik, Giessen, Germany )

Overview of multiple myeloma with Maria Victoria Mateos

Dr Maria-Victoria Mateos - University Hospital of Salamanca, Spain

Overview of multiple myeloma with Maria Victoria Mateos ( Dr Maria-Victoria Mateos - University Hospital of Salamanca, Spain )

Advances and updates in treatments for myeloma presented at ASH 2012

Prof Keith Stewart - Mayo Clinic, Scottsdale, USA

Advances and updates in treatments for myeloma presented at ASH 2012 ( Prof Keith Stewart - Mayo Clinic, Scottsdale, USA )

Advances in myeloma at ASH 2012 (2/2)

Prof Gareth Morgan - The Royal Marsden Hospital, London

Advances in myeloma at ASH 2012 (2/2) ( Prof Gareth Morgan - The Royal Marsden Hospital, London )

Advances in myeloma at ASH 2012 (1/2)

Prof Gareth Morgan - The Royal Marsden Hospital, London

Advances in myeloma at ASH 2012 (1/2) ( Prof Gareth Morgan - The Royal Marsden Hospital, London )

Pre-Implantation genetic diagnosis

Dr Alison Lashwood - Guy's Hospital, London, UK

Pre-Implantation genetic diagnosis ( Dr Alison Lashwood - Guy's Hospital, London, UK )

The Childhood Cancer Survivor Study (CCSS) and the Women's Environmental Cancer...

Dr Chaya Moskowitz - Memorial Sloan Kettering Cancer Center, New York, USA

The Childhood Cancer Survivor Study (CCSS) and the Women's Environmental Cancer and Radiation Epidemiology (WECARE) Study ( Dr Chaya Moskowitz - Memorial Sloan Kettering Cancer Center, New York, USA )

MLN9708 in combination with lenalidomide and dexamethasone against multiple...

Dr Shaji Kumar - Mayo Clinic, Rochester, USA

MLN9708 in combination with lenalidomide and dexamethasone against multiple myeloma ( Dr Shaji Kumar - Mayo Clinic, Rochester, USA )

PACE Trial: Phase II trial of ponatinib in patients with chronic myeloid...

Dr Jorge Cortes - MD Anderson Cancer Center, Houston, TX, USA

PACE Trial: Phase II trial of ponatinib in patients with chronic myeloid leukaemia (CML) ( Dr Jorge Cortes - MD Anderson Cancer Center, Houston, TX, USA )

Pomalidomide with low-dose vs. high-dose dexamathasone in refractory patients

Professor Meletios Dimopoulos - University of Athens, Greece

$Pomalidomide with low-dose vs. high-dose dexamathasone in refractory patients ( Professor Meletios Dimopoulos - University of Athens, Greece )$

MLN9708 in combination with lenalidomide and dexamethasone

Dr Shaji Kumar - Mayo Clinic, Rochester, USA

MLN9708 in combination with lenalidomide and dexamethasone ( Dr Shaji Kumar - Mayo Clinic, Rochester, USA )

History of epidermal stem cell use in the clinical setting

Prof Michele De Luca - University of Modena e Reggio Emilia, Modena, Italy

History of epidermal stem cell use in the clinical setting ( Prof Michele De Luca - University of Modena e Reggio Emilia, Modena, Italy )

More from ecancer